"So why would Suzy Jones previously the head of business development at a multi billion dollar pharmaceutical company come here? with a micro cap of $11M but a portfolio of novel human antibody treatments for cancer entering clinical trials & setting up to be outlicensed."
I should of made this more clear in my post aswell, it was the end of a 4 day weekend.. :-)
Genentech was not so much a pharmaceutical company as the oldest & largest R&D company before Roche stepped up & took out the remaining stake they didn't already own. So Suzy Jones as Head of Business Development at the largest & oldest R&D company globally with it's top of the line focus in Oncology & antibody drugs in market.
You think she's here because the science sucks ?
the demise of csl, page-9
Add PAB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.4¢ |
Change
0.001(16.7%) |
Mkt cap ! $6.172M | |||
| Open | High | Low | Value | Volume |
| 0.4¢ | 0.4¢ | 0.3¢ | $8.832K | 2.911M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 42 | 32274912 | 0.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.4¢ | 27089307 | 15 |
View Market Depth
| Last trade - 13.52pm 04/10/2024 (20 minute delay) ? |
| PAB (ASX) Chart |